These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 36672364)
21. Gene panel testing of 5589 BRCA1/2-negative index patients with breast cancer in a routine diagnostic setting: results of the German Consortium for Hereditary Breast and Ovarian Cancer. Hauke J; Horvath J; Groß E; Gehrig A; Honisch E; Hackmann K; Schmidt G; Arnold N; Faust U; Sutter C; Hentschel J; Wang-Gohrke S; Smogavec M; Weber BHF; Weber-Lassalle N; Weber-Lassalle K; Borde J; Ernst C; Altmüller J; Volk AE; Thiele H; Hübbel V; Nürnberg P; Keupp K; Versmold B; Pohl E; Kubisch C; Grill S; Paul V; Herold N; Lichey N; Rhiem K; Ditsch N; Ruckert C; Wappenschmidt B; Auber B; Rump A; Niederacher D; Haaf T; Ramser J; Dworniczak B; Engel C; Meindl A; Schmutzler RK; Hahnen E Cancer Med; 2018 Apr; 7(4):1349-1358. PubMed ID: 29522266 [TBL] [Abstract][Full Text] [Related]
22. Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers in a large cohort of unselected Chinese breast cancer patients. Su L; Xu Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y Int J Cancer; 2020 Jun; 146(12):3335-3342. PubMed ID: 32037537 [TBL] [Abstract][Full Text] [Related]
23. Detection of Germline Mutations in a Cohort of 139 Patients with Bilateral Breast Cancer by Multi-Gene Panel Testing: Impact of Pathogenic Variants in Other Genes beyond Fanale D; Incorvaia L; Filorizzo C; Bono M; Fiorino A; Calò V; Brando C; Corsini LR; Barraco N; Badalamenti G; Russo A; Bazan V Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32854451 [TBL] [Abstract][Full Text] [Related]
24. Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population. Reiner AS; Lynch CF; Sisti JS; John EM; Brooks JD; Bernstein L; Knight JA; Hsu L; Concannon P; Mellemkjær L; Tischkowitz M; Haile RW; Shen R; Malone KE; Woods M; Liang X; Morrow M; Bernstein JL; Breast Cancer Res; 2017 Jul; 19(1):83. PubMed ID: 28724391 [TBL] [Abstract][Full Text] [Related]
25. Reproductive factors and risk of contralateral breast cancer by BRCA1 and BRCA2 mutation status: results from the WECARE study. Poynter JN; Langholz B; Largent J; Mellemkjaer L; Bernstein L; Malone KE; Lynch CF; Borg A; Concannon P; Teraoka SN; Xue S; Diep AT; Törngren T; Begg CB; Capanu M; Haile RW; ; Bernstein JL Cancer Causes Control; 2010 Jun; 21(6):839-46. PubMed ID: 20130978 [TBL] [Abstract][Full Text] [Related]
27. Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria. Hoyer J; Vasileiou G; Uebe S; Wunderle M; Kraus C; Fasching PA; Thiel CT; Hartmann A; Beckmann MW; Lux MP; Reis A BMC Cancer; 2018 Sep; 18(1):926. PubMed ID: 30257646 [TBL] [Abstract][Full Text] [Related]
28. Frequency of Pathogenic Germline Mutations in Early and Late Onset Familial Breast Cancer Patients Using Multi-Gene Panel Sequencing: An Egyptian Study. Nassar A; Zekri AN; Kamel MM; Elberry MH; Lotfy MM; Seadawy MG; Hassan ZK; Soliman HK; Lymona AM; Youssef ASE Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672847 [TBL] [Abstract][Full Text] [Related]
29. Germline variants in DNA repair genes associated with hereditary breast and ovarian cancer syndrome: analysis of a 21 gene panel in the Brazilian population. da Costa E Silva Carvalho S; Cury NM; Brotto DB; de Araujo LF; Rosa RCA; Texeira LA; Plaça JR; Marques AA; Peronni KC; Ruy PC; Molfetta GA; Moriguti JC; Carraro DM; Palmero EI; Ashton-Prolla P; de Faria Ferraz VE; Silva WA BMC Med Genomics; 2020 Feb; 13(1):21. PubMed ID: 32039725 [TBL] [Abstract][Full Text] [Related]
30. High risk of contralateral breast carcinoma in women with hereditary/familial non-BRCA1/BRCA2 breast carcinoma. Shahedi K; Emanuelsson M; Wiklund F; Gronberg H Cancer; 2006 Mar; 106(6):1237-42. PubMed ID: 16475207 [TBL] [Abstract][Full Text] [Related]
31. Detection of pathogenic variants in breast cancer susceptibility genes in bilateral breast cancer. Evans DG; Burghel GJ; Schlecht H; Harkness EF; Gandhi A; Howell SJ; Howell A; Forde C; Lalloo F; Newman WG; Smith MJ; Woodward ER J Med Genet; 2023 Oct; 60(10):974-979. PubMed ID: 37055167 [TBL] [Abstract][Full Text] [Related]
32. Characterization of genetic predisposition to molecular subtypes of breast cancer in Brazilian patients. Paixão D; Torrezan GT; Santiago KM; Formiga MN; Ahuno ST; Dias-Neto E; Tojal da Silva I; Foulkes WD; Polak P; Carraro DM Front Oncol; 2022; 12():976959. PubMed ID: 36119527 [TBL] [Abstract][Full Text] [Related]
33. Frequency of Pathogenic Germline Variants in Petridis C; Arora I; Shah V; Moss CL; Mera A; Clifford A; Gillett C; Pinder SE; Tomlinson I; Roylance R; Simpson MA; Sawyer EJ Cancer Epidemiol Biomarkers Prev; 2019 Jul; 28(7):1162-1168. PubMed ID: 31263054 [TBL] [Abstract][Full Text] [Related]
34. Whole-exome sequencing and targeted gene sequencing provide insights into the role of PALB2 as a male breast cancer susceptibility gene. Silvestri V; Zelli V; Valentini V; Rizzolo P; Navazio AS; Coppa A; Agata S; Oliani C; Barana D; Castrignanò T; Viel A; Russo A; Tibiletti MG; Zanna I; Masala G; Cortesi L; Manoukian S; Azzollini J; Peissel B; Bonanni B; Peterlongo P; Radice P; Palli D; Giannini G; Chillemi G; Montagna M; Ottini L Cancer; 2017 Jan; 123(2):210-218. PubMed ID: 27648926 [TBL] [Abstract][Full Text] [Related]
35. Risk factors for contralateral breast cancer in Chennai (Madras), India. Gajalakshmi CK; Shanta V; Hakama M Int J Epidemiol; 1998 Oct; 27(5):743-50. PubMed ID: 9839728 [TBL] [Abstract][Full Text] [Related]
36. Fanconi Anaemia, Childhood Cancer and the Woodward ER; Meyer S Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680915 [TBL] [Abstract][Full Text] [Related]
38. Management Strategies of Breast Cancer Patients with Edaily S; Abdel-Razeq H Onco Targets Ther; 2022; 15():815-826. PubMed ID: 35923470 [TBL] [Abstract][Full Text] [Related]
39. Optimization of prediction methods for risk assessment of pathogenic germline variants in the Japanese population. Senda N; Kawaguchi-Sakita N; Kawashima M; Inagaki-Kawata Y; Yoshida K; Takada M; Kataoka M; Torii M; Nishimura T; Kawaguchi K; Suzuki E; Kataoka Y; Matsumoto Y; Yoshibayashi H; Yamagami K; Tsuyuki S; Takahara S; Yamauchi A; Shinkura N; Kato H; Moriguchi Y; Okamura R; Kan N; Suwa H; Sakata S; Mashima S; Yotsumoto F; Tachibana T; Tanaka M; Togashi K; Haga H; Yamada T; Kosugi S; Inamoto T; Sugimoto M; Ogawa S; Toi M Cancer Sci; 2021 Aug; 112(8):3338-3348. PubMed ID: 34036661 [TBL] [Abstract][Full Text] [Related]
40. Contralateral Breast Cancer and Ipsilateral Breast Tumor Recurrence in Yoon KH; Chae S; Kang E; Shin HC; Kim JH; Kim IA; Park SY; Kim SW; Kim EK J Breast Cancer; 2019 Dec; 22(4):587-598. PubMed ID: 31897332 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]